New study aims to measure what matters most for kids with tough brain cancers
NCT ID NCT04670016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at how re-irradiation affects the quality of life and symptoms of 20 children with diffuse intrinsic pontine glioma (DIPG) or recurrent brain tumors, as well as their caregivers. Researchers used surveys to track physical, emotional, and social well-being over time. The goal was to better understand the real-world benefits and burdens of this treatment, not to test a new drug or cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better understand how re-irradiation affects children's quality of life and guide supportive care for families.
What could go wrong
This is a small, non-therapeutic study with only 20 participants, so results may not apply broadly. It does not test a new treatment or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION EXPOSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8, Canada
-
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
CHU de Quebec-Universite Laval
Québec, G1V 4G2, Canada
-
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
-
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, H3T 1C5, Canada
-
Children's Hospital
London, Ontario, N6A 5W9, Canada
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
-
IWK Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Stollery Children's Hospital
Edmonton, Alberta, T6G 2B7, Canada
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada